N. Yoda

发表

Structure-activity relationships for mitomycins. Application of the distance and charge analysis method.

N. Hirayama, N. Yoda, 1993, Journal of medicinal chemistry.

Design and synthesis of potent antitumor 5,4'-diaminoflavone derivatives based on metabolic considerations.

E. Fuse, K. Gomi, S. Kobayashi, 1997, Journal of medicinal chemistry.

An efficient chemical conversion of mitomycin A to isomitomycin A

N. Hirayama, M. Kasai, S. Ikeda, 1992 .

5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.

I. Miki, A. Ishii, F. Suzuki, 1993, Journal of medicinal chemistry.

5-HT3 receptor antagonists. 1. New quinoline derivatives.

I. Miki, A. Ishii, F. Suzuki, 1992, Journal of medicinal chemistry.

Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.

Mitsunobu Hara, S. Soga, S. Akinaga, 2007, Bioorganic & medicinal chemistry.

Conformation Analysis of Sialyl LeX by Molecular Mechanics

N. Hirayama, N. Yoda, Tatunari Nishi, 1994 .

The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family.

K. Sasaki, T. Kitayama, Kazunori Hirayama, 2010, European journal of pharmacology.

Theoretical study of hydrated Be2+ ions

S. Iwata, K. Hashimoto, N. Yoda, 1987 .

Chemistry of neocarzinostatin-mediated cleavage of oligonucleotides. Competitive ribose C5' and C4' hydroxylation

H. Sugiyama, T. Fujiwara, I. Saito, 1992 .